Carlyle, Brighton Park to invest $200 mn in Bengaluru firm, Indegene
Updated:
Updated:
February 03, 2021 01:33 IST
Indegene had made significant organic and inorganic investments in building a technology portfolio that caters exclusively to healthcare.
Share Article
AAA
Indegene had made significant organic and inorganic investments in building a technology portfolio that caters exclusively to healthcare.
The Carlyle Group and Brighton Park Capital, an investor-centric investment firm, will acquire a minority stake in Bengaluru-based Indegene Lifesystems, an enterprise healthtech solutions provider, for $200 million (around Rs 1,500 crore).
The transaction, which is subject to customary regulatory approvals, consists of a secondary sale from existing shareholders of Indegene and a primary investment into the company, said Carlyle Group and Brighton Park Capital in a joint statement on Wednesday.